SCHEMBL13586458

SCHEMBL13586458

N#Cc1cc(Cl)cc(Oc2c(Cl)ccc(CC(=O)Nc3ccc(S)cc3Cl)c2F)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.48
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
RORC P51449 1/20 0.36
IDO1 P14902 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KCNH2 Q12809 2/20 0.33
GALR3 O60755 1/20 0.33
NR2F2 P24468 1/20 0.33
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
MEN1 O00255 1/20 0.33
PSMD14 O00487 1/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 1/20 0.33
PDK1 Q15118 1/20 0.32
PDK2 Q15119 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13492229 0.92 CYP3A4 (0.51) CYP3A4CYP2C9CYP2C19RORCIDO1
SCHEMBL3914677 0.89 CYP3A4 (0.46) CYP3A4CYP2C9CYP2C19RORCIDO1
SCHEMBL2638669 0.88 CYP3A4 (0.48) CYP3A4CYP2C9CYP2C19RORCIDO1
SCHEMBL2637899 0.86 CA1 (0.49) CYP3A4CA12CA1CA2CA9
SCHEMBL2639248 0.85 CYP3A4 (0.46) CYP3A4CYP2C9CYP2C19RORCKCNH2
SCHEMBL13492244 0.84 RORC (0.43) CYP3A4CYP2C9CYP2C19RORCIDO1
SCHEMBL13586655 0.84 CYP3A4 (0.43) CYP3A4CYP2C9CYP2C19RORCKCNH2
SCHEMBL2639193 0.83 CYP3A4 (0.42) CYP3A4CYP2C9CYP2C19RORCIDO1
SCHEMBL13586645 0.83 CYP3A4 (0.38) CYP3A4CYP2C9CYP2C19RORCNPC1
SCHEMBL2639564 0.83 RORC (0.44) CYP3A4CYP2C9CYP2C19RORCNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625949-B2 Methods for treating retroviral infections ROCHE PALO ALTO LLC (US) 2009-12-01 US disclosed